Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Pujol Autonell, Irma ^a   Serracant Prat, Arnau ^a   Cano Sarabia, Mary ^b   Ampudia, Rosa M ^a   Rodriguez Fernandez, Silvia ^a   Sanchez, Alex ^c   Izquierdo, Cristina ^c   Stratmann, Thomas ^c   Puig Domingo, Manuel ^d   Maspoch, Daniel ^b,e   Verdaguer, Joan ^f   Vives Pi, Marta ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f UNIVERSITY OF LLEIDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INSULIN; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHATIDYLSERINE; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; T LYMPHOCYTE; ANIMAL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; PHENOTYPE; SECRETION (PROCESS);

MUS;

ANIMALS; AUTOANTIGENS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; IMMUNOTHERAPY; INJECTIONS, INTRAPERITONEAL; INSULIN; LIPOSOMES; MICE, INBRED NOD; PHENOTYPE; PHOSPHATIDYLSERINES;

EID: 84935019320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127057     Document Type: Article

References (56)

1. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. The Journal of experimental medicine. 2000;191(3):411-6. PMID: 10662786; PubMed Central PMCID: PMC2195815.
2. Hochreiter-Hufford A, Ravichandran KS. Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harbor perspectives in biology. 2013;5(1):a008748. doi: 10.1101/cshperspect.a008748 PMID: 23284042.
3. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. The Journal of clinical investigation. 2001;108(7):957-62. doi: 10.1172/JCI14122 PMID: 11581295; PubMed Central PMCID: PMC200959.
4. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell. 2010;140(5):619-30. doi: 10.1016/j.cell.2010.02.014 PMID: 20211132.
5. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nature reviews Endocrinology. 2009;5(4):219-26. doi: 10.1038/nrendo.2009.21 PMID: 19352320.
6. O'Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. Journal of autoimmunity. 2006;26(2):104-15. doi: 10.1016/j.jaut.2005.11.006 PMID: 16431079.
7. Marin-Gallen S, Clemente-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, et al. Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes. Clinical and experimental immunology. 2010;160(2):207-14. doi: 10.1111/j.1365-2249.2009.04082.x PMID: 20030670; PubMed Central PMCID: PMC2857943.
8. Pujol-Autonell I, Ampudia RM, Planas R, Marin-Gallen S, Carrascal J, Sanchez A, et al. Efferocytosis promotes suppressive effects on dendritic cells through prostaglandin E2 production in the context of autoimmunity. PloS one. 2013;8(5):e63296. doi: 10.1371/journal.pone.0063296 PMID: 23691013; PubMed Central PMCID: PMC3654963.
9. Fenske DB, Cullis PR. Liposomal nanomedicines. Expert opinion on drug delivery. 2008;5(1):25-44. doi: 10.1517/17425247.5.1.25 PMID: 18095927.
10. Mitragotri S, Yoo JW. Designing micro- and nano-particles for treating rheumatoid arthritis. Archives of pharmacal research. 2011;34(11):1887-97. doi: 10.1007/s12272-011-1109-9 PMID: 22139688.
11. Clemente-Casares X, Santamaria P. Nanomedicine in autoimmunity. Immunology letters. 2014;158(1-2):167-74. doi: 10.1016/j.imlet.2013.12.018 PMID: 24406504.
12. Ramos GC, Fernandes D, Charao CT, Souza DG, Teixeira MM, Assreuy J. Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo. British journal of pharmacology. 2007;151(6):844-50. doi: 10.1038/sj.bjp. 0707302 PMID: 17533418; PubMed Central PMCID: PMC2014119.
13. Martin DS, Walsh M, Miller AM, Skerrett HE, Byrne P, Mandel A, et al. A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat. Neuroimmunomodulation. 2009;16(6):400-10. doi: 10.1159/000228915 PMID: 19609089.
14. Wu Z, Ma HM, Kukita T, Nakanishi Y, Nakanishi H. Phosphatidylserine-containing liposomes inhibit the differentiation of osteoclasts and trabecular bone loss. Journal of immunology. 2010;184(6):3191-201. doi: 10.4049/jimmunol.0803609 PMID: 20176740.
15. Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(5):1827-32. doi: 10.1073/pnas.1015623108 PMID: 21245355; PubMed Central PMCID: PMC3033268.
16. Chen X, Doffek K, Sugg SL, Shilyansky J. Phosphatidylserine regulates the maturation of human dendritic cells. Journal of immunology. 2004;173(5):2985-94. PMID: 15322157.
17. Presa M, Ortiz AZ, Garabatos N, Izquierdo C, Rivas EI, Teyton L, et al. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice. European journal of immunology. 2013;43(11):2969-79. doi: 10.1002/eji.201343633 PMID: 23925934; PubMed Central PMCID: PMC3856580.
18. Pugliese A. Central and peripheral autoantigen presentation in immune tolerance. Immunology. 2004;111(2):138-46. doi: 10.1111/j.0019-2805.2003.01804.x PMID: 15027898; PubMed Central PMCID: PMC1782408.
19. Stratmann T, Martin-Orozco N, Mallet-Designe V, Poirot L, McGavern D, Losyev G, et al. Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity. The Journal of clinical investigation. 2003;112(6):902-14. doi: 10.1172/JCI18337 PMID: 12975475; PubMed Central PMCID: PMC193666.
20. Alba A, Puertas MC, Carrillo J, Planas R, Ampudia R, Pastor X, et al. IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice. Journal of immunology. 2004;173(11):6667-75. PMID: 15557158.
21. Stratmann T, Apostolopoulos V, Mallet-Designe V, Corper AL, Scott CA, Wilson IA, et al. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. Journal of immunology. 2000;165(6):3214-25. PMID: 10975837.
22. Corper AL, Stratmann T, Apostolopoulos V, Scott CA, Garcia KC, Kang AS, et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science. 2000;288(5465):505-11. PMID: 10775108.
23. Yoshida K, Martin T, Yamamoto K, Dobbs C, Munz C, Kamikawaji N, et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. International immunology. 2002;14(12):1439-47. PMID: 12456592.
24. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes. 1988;37(10):1444-8. PMID: 2458291.
25. Hillaireau H, Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cellular and molecular life sciences: CMLS. 2009;66(17):2873-96. doi: 10.1007/s00018-009-0053-z PMID: 19499185.
26. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350-1. doi: 10.1038/37022 PMID: 9389474.
27. Ulrich AS. Biophysical aspects of using liposomes as delivery vehicles. Bioscience reports. 2002;22(2):129-50. PMID: 12428898.
28. Smith DM, Simon JK, Baker JR Jr. Applications of nanotechnology for immunology. Nature reviews Immunology. 2013;13(8):592-605. doi: 10.1038/nri3488 PMID: 23883969.
29. Endruschat J, Henschke K. Bench scale manufacture of multilamellar liposomes using a newly developed multistage pressure filtration device. International journal of pharmaceutics. 2000;196(2):151-3. PMID: 10699707.
30. Latif N, Bachhawat BK. Liposomes in immunology. J Biosci. 1984;6(4):491-502. PMID: 6713089.
31. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. The Journal of clinical investigation. 2002;109(1):41-50. doi: 10.1172/JCI11638 PMID: 11781349; PubMed Central PMCID: PMC150814.
32. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: implications in health and disease. The Journal of cell biology. 2010;189(7):1059-70. doi: 10.1083/jcb.201004096 PMID: 20584912; PubMed Central PMCID: PMC2894449.
33. Foged C, Arigita C, Sundblad A, Jiskoot W, Storm G, Frokjaer S. Interaction of dendritic cells with antigencontaining liposomes: effect of bilayer composition. Vaccine. 2004;22(15-16):1903-13. doi: 10. 1016/j.vaccine.2003.11.008 PMID: 15121302.
34. Shi D, Fu M, Fan P, Li W, Chen X, Li C, et al. Artificial phosphatidylserine liposome mimics apoptotic cells in inhibiting maturation and immunostimulatory function of murine myeloid dendritic cells in response to 1-chloro-2, 4-dinitrobenze in vitro. Archives of dermatological research. 2007;299(7):327-36. doi: 10.1007/s00403-007-0770-9 PMID: 17643252.
35. Daniel D, Wegmann DR. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proceedings of the National Academy of Sciences of the United States of America. 1996;93(2):956-60. PMID: 8570667; PubMed Central PMCID: PMC40166.
36. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proceedings of the National Academy of Sciences of the United States of America. 1991;88(22):10252-6. PMID: 1946445; PubMed Central PMCID: PMC52906.
37. Thebault-Baumont K, Dubois-Laforgue D, Krief P, Briand JP, Halbout P, Vallon-Geoffroy K, et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. The Journal of clinical investigation. 2003;111(6):851-7. doi: 10.1172/JCI16584 PMID: 12639991; PubMed Central PMCID: PMC153768.
38. Lutsiak ME, Kwon GS, Samuel J. Analysis of peptide and lipopeptide content in liposomes. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2002;5(3):279-84. PMID: 12553897.
39. Blachere NE, Darnell RB, Albert ML. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS biology. 2005;3(6):e185. doi: 10.1371/journal.pbio.0030185 PMID: 15839733; PubMed Central PMCID: PMC1084338.
40. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, Serra P, et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity. 2010;32(4):568-80. doi: 10.1016/j. immuni.2010.03.015 PMID: 20381385.
41. Tsai S, Clemente-Casares X, Santamaria P. CD8 (+) Tregs in autoimmunity: learning "self"-control from experience. Cellular and molecular life sciences: CMLS. 2011;68(23):3781-95. doi: 10.1007/s00018-011-0738-y PMID: 21671120.
42. Verginis P, Li HS, Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. Journal of immunology. 2005;174(11):7433-9. PMID: 15905592.
43. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. The American journal of pathology. 1995;147(5):1193-9. PMID: 7485382; PubMed Central PMCID: PMC1869521.
44. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. The Journal of clinical investigation. 1998;101(4):890-8. doi: 10.1172/JCI1112 PMID: 9466984; PubMed Central PMCID: PMC508637.
45. Zhang J, Fujii S, Wu Z, Hashioka S, Tanaka Y, Shiratsuchi A, et al. Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia. Journal of neuroimmunology. 2006;172(1-2):112-20. doi: 10.1016/j.jneuroim.2005.11. 008 PMID: 16371234.
46. Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes. 2011;60(8):2112-9. doi: 10.2337/db10-1643 PMID: 21659501; PubMed Central PMCID: PMC3142078.
47. Mueller C, Tschumper A, Tschumper JC, Hess MW, Cottier H. Parathymic lymph node: oriented proliferative response of the murine thymic cortex to intraperitoneal stimulation. Thymus. 1987;9(1):3-12. PMID: 3576665.
48. Allen TM, Hansen CB, Guo LS. Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochimica et biophysica acta. 1993;1150(1):9-16. PMID: 8334142.
49. Buiting AM, De Rover Z, Claassen E, Van Rooijen N. In vivo distribution of particulate antigens and liposomes in murine spleen. A possible role in the humoral immune response. Immunobiology. 1993;188(1-2):13-22. doi: 10.1016/S0171-2985 (11) 80483-3 PMID: 8406555.
50. Creusot RJ, Yaghoubi SS, Chang P, Chia J, Contag CH, Gambhir SS, et al. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood. 2009;113(26):6638-47. doi: 10.1182/blood-2009-02-204321 PMID: 19363220; PubMed Central PMCID: PMC2710920.
51. Diana J, Simoni Y, Furio L, Beaudoin L, Agerberth B, Barrat F, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nature medicine. 2013;19(1):65-73. doi: 10.1038/nm.3042 PMID: 23242473.
52. Carrero JA, Calderon B, Towfic F, Artyomov MN, Unanue ER. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PloS one. 2013;8(3):e59701. doi: 10.1371/journal. pone.0059701 PMID: 23555752; PubMed Central PMCID: PMC3608568.
53. Panus JF, McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific T helper cell function: differential cytokine expression in primary and memory responses. The Journal of experimental medicine. 2000;192(9):1301-16. PMID: 11067879; PubMed Central PMCID: PMC2193351.
54. Biermann M, Maueroder C, Brauner JM, Chaurio R, Janko C, Herrmann M, et al. Surface code-biophysical signals for apoptotic cell clearance. Physical biology. 2013;10(6):065007. doi: 10.1088/1478-3975/10/6/065007 PMID: 24305041.
55. Hall BM, Verma ND, Tran GT, Hodgkinson SJ. Distinct regulatory CD4+T cell subsets; differences between naive and antigen specific T regulatory cells. Current opinion in immunology. 2011;23(5):641-7. doi: 10.1016/j.coi.2011.07.012 PMID: 21840184.
56. Roep BO, Atkinson M, Von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nature reviews Immunology. 2004;4(12):989-97. doi: 10.1038/nri1502 PMID: 15573133.